Investigations of molecules at the Desy: A robotic arm helped to quickly change samples
Photo: Marta Mayer / DESY
Hydroxychloroquine, remdesivir and dexamethasone - since the coronavirus spread across the world, experts have tested a wide range of drugs against the Covid-19 disease.
So far, the success has been rather manageable.
Some drugs turned out to be completely ineffective, such as hydroxychloroquine.
With dexamethasone, timing the treatment is what matters.
And with Remdesivir, there is still no clear evidence of any benefit.
In short: there is no really effective drug a good year after the Sars-CoV-2 was first detected.
No drug that reliably helps against Covid-19, which prevents months of fatigue even after mild courses or long-term damage to the lungs.
Such a means would be a crucial building block in order to reduce the effects of the pandemic, to relieve intensive care units and to reduce the damage to society.
Such an active ingredient would be all the more important because the vaccination campaigns will drag on for many months.
Anyone who cannot or does not want to be vaccinated would benefit from a drug in the event of an infection.
Read more with Spiegel Plus
More perspectives, more understanding.
Your advantages with SPIEGEL +
SPIEGEL as a magazine
as an app, e-paper and on the e-reader
All articles on SPIEGEL.de
Exclusive texts for SPIEGEL + readers
Try one month for free
Cancel anytime online
only € 19.99 per month
One month for € 0.00
Try now for 0.00 € Buy nowArrow to the right
Already have a digital subscription? Register here
Restore iTunes subscription
SPIEGEL + is processed via your iTunes account and paid for with a purchase confirmation.
24 hours before it expires, the subscription is automatically renewed by one month at the current price of € 19.99.
You can cancel the subscription at any time in the settings of your iTunes account.
In order to use SPIEGEL + outside of this app, you have to link the subscription to a SPIEGEL ID account immediately after purchase.